Thursday 12 May 2011
A vaccine for pancreatic cancer, which has the lowest survival rate of all cancers, has begun in the UK. The TeloVac vaccine is being trialled on over a thousand patients with advanced pancreatic cancer. More from the BBC
Recent stories
Most people told to get a colonoscopy don't
>> Find out more
MASCC/ISOO early rate deadline approaching
>> Find out more
Ten biomarkers for lung cancer detection
>> Find out more
Book for high-level conference on health funding
>> Find out more
New strategy to help charities deal with fraud
>> Find out more
Seminar on financial sustainability for charities
>> Find out more
Diesel exhaust linked to lung cancer deaths
>> Find out more
Identify depressive symptoms early in breast cancer patients
>> Find out more
Antibiotics may help gastric DLBCL patients avoid chemo
>> Find out more
Early registration deadline for GI conference extended to Fri
>> Find out more
Medical paternalism: who knows best?
>> Find out more
Risk of fatal adverse events in VEGF-targeting cancer drugs
>> Find out more
EBMT 2012: registration open
>> Find out more
Latest issue of Human Medicines Highlights available
>> Find out more
No to abiraterone in England & Wales
>> Find out more
Vitamin E supplements linked to prostate cancer risk
>> Find out more
Aspirin: cancer prevention benefits outweigh risks for 55-75 age group
>> Find out more
How does prenatal chemotherapy exposure affect children?
>> Find out more
Colonoscopy with adenoma removal cut colorectal cancer deaths by 53%
>> Find out more
Warning about counterfeit Avastin
>> Find out more